Dispersions in transcutol/isopropyl myristate make C 60 fullerene molecules suitable for transdermal delivery. We found that C 60 can successfully permeate the skin using pig skin in Franz diffusion cells. Molecular dynamics simulations and transmission electron microscopy confirmed these observations. Basic cosmetic formulations with transcutol/isopropyl myristate without harsh organic solvents show a high potential for delivery of C 60 for biopharmaceutical and cosmetics applications.
Introduction
Fullerenes are hydrophobic molecules composed of carbon atoms arranged in a spherical geometry with a hollow interior. In fullerenes, carbon atoms are typically interconnected by alternating length bonds. Thus, presents sp 2 carbon atoms hybridization arranged in hexagons and pentagons [1] . Fullerenes have attracted much attention of researchers from the discovery of their potential as a potent antioxidant [2] [3] [4] . Fullerenes are capable of scavenging free radicals including reactive oxygen and nitrogen species [5, 6] . These reactive species are generated in cells, and their presence induces cellular instability that leads to damage and ultimately cell death. Antioxidants are molecules able to perform the elimination or neutralization of free radical electrons. The benefits of antioxidants have been extensively investigated, particularly in general heath (e.g. extending the lifespan) or in skin aging (delaying the normal aging process) [7, 8] .
Fullerene C 60 can exhibit antioxidant functionality as it readily reacts with many free radicals deactivating them effectively. The discovery of this buckminsterfullerene, a stable and very symmetrical structure (carbon cluster) with 60 atoms, opened up an innovative way to treat a wide range of pathologies and diseases [9] . This include, radiation exposure [10] , degenerative process related with skin aging [11] , degenerative diseases (Parkinson's, Alzheimer's, multiple sclerosis) [12, 13] , osteoporosis [14] , and, in general, inflammatory processes [15] . However, potential applications ranging from cosmetic/pharmaceutical to medical treatments have been impaired due to the fact that C 60 is insoluble in water and polar solvents. Several solvents have been explored to solubilize fullerene C 60 [16] [17] [18] [19] . The toxicity Correspondence: Dr. Artur Cavaco-Paulo (artur@deb.uminho.pt), Centre of Biological Engineering, University of Minho, 4710-057 Braga, Portugal Abbreviations: IPM, isopropyl myristate; LLE, liquid-liquid extraction; TEM, transmission electron microscopy; TRC, transcutol of C 60 fullerene is dependent of its structure, composition, and morphology [20] . The generalization about C 60 fullerene toxicity it is ambiguous because it is dependent of several factors, such as, dose and time-dependent, functional groups in the case of functionalization, method of administration among others [21] . Therefore, future toxicological studies will be crucial for safety and effective methodologies.
To overcome the water solubility problem of C 60 different biocompatible approaches is required. Fullerene derivatives have been developed for instance by covalent functionalization with hydrophilic chemical groups or by the encapsulation into supramolecular complexes such as cyclodextrin or polyvinylpyrrolidone [22, 23] . Further research demonstrated the solubility of fullerene C 60 in fatty acids [24, 25] that allowed the possibility to use fatty acid esters of glycerol or others, for the delivery of fullerene and fullerene derivatives in living organisms [26] . Based on this, we developed herein dispersions of fullerene C 60 in fatty acids suitable for transdermal application. As far as we know there is no cosmetic/pharmaceutical formulation available using fullerene C 60 in isopropyl myristate and/or transcutol. These dispersions make fullerene C 60 suitable to be delivered transdermally by direct application in the skin without harsh organic solvents or any chemical modification or encapsulation process.
Materials and methods

Materials
Fullerene C 60 (purity: 99.5%) and isopropyl myristate (IPM) were purchased from Sigma-Aldrich (Spain). Transcutol (TRC) (diethylene glycol monoethyl ether) was kindly provided from Gattefossé Corporation (France). The skin permeation study was performed using pig skin that was kindly supplied by a slaughterhouse (Matadouro Central de Entre Douro e Minho, Portugal). All reagents were used as received without further purification.
Preparation method of fullerene C 60 dispersions
The preparation of the fullerene C 60 dispersions were as follows. The solid fullerene C 60 was dispersed in water, in IPM and in IPM with 20% transcutol to a final concentration of 0.8 mg/mL of C 60 for all solutions. The dispersions were vigorously stirred for 3 h at a room temperature with a magnetic stirrer.
In vitro permeation studies
The permeation profile was undertaken on a Franz diffusion cell (V-Series Franz Cells, PermeGear, USA). This apparatus consists of three cells, each one with a donor and receptor compartment. The pig skin specimen was mounted between the donor and receptor compartments, and 300 μL of the dispersion solution of C 60 was placed on the top of the skin surface in the donor compartment. The receptor compartment was filled with 5 mL of 0.01 M phosphate buffered saline (pH 7.4) that was continuously stirred. The receptor liquid was maintained at 37°C using a circulating water bath for 24 h. A control sample was run in parallel with each assay.
The quantification of C 60 in the receptor and donor compartments was determined by a simple liquid-liquid extraction (LLE) method. The experiments were carried out by mixing equal volumes of aqueous and organic (toluene) phases (5 mL). After extraction from the sample solution fullerene C 60 was quantified by UV-vis spectroscopy.
Transmission electron spectroscopy
To visualize the C 60 dispersions morphology into the skin, the samples were fixed with 2.5% glutaraldehyde and 2% paraformaldehyde in cacodylate buffer 0.1 M (pH 7.4). After post fixed in 2% osmium tetroxide in the same buffer, the samples were dehydrated with ethanol, carefully cut off, and embedded in Epon resin. Ultrathin sections (40-60 nm thickness) were prepared on a RMC Ultramicrotome (PowerTome, USA) using diamond knives (DDK, Wilmington, DE, USA). The sections were mounted on 200 mesh copper or nickel grids, stained with uranyl acetate and lead citrate for 5 min each, and examined under a JEOL JEM 1400 TEM (Tokyo, Japan). Images were digitally recorded using a CCD digital camera Orious 1100 W Tokyo, Japan.
Molecular dynamics simulations
The simulations were performed with GROMACS 4.6 [27] package using Martini force field [28] . The system size was chosen according to the minimum image convention taking into account a cut-off of 1.2 nm. The bonds lengths were constrained with LINCS [29] . Nonbonded interactions were calculated using a twin-range method, with short and long range cut-offs of 0.9 and 1.2 nm, respectively. Neighbor searching was carried out up to 1.2 nm and updated every ten steps. A time step of integration of 20 fs was used. A reaction field correction for the electrostatic interactions was applied using a dielectric constant of 15. Pressure control was implemented using the Berendsen barostat [30] , with a reference pressure of 1 bar, 3.0 ps of relaxation time and isothermal compressibility of 3.0 × 10 −5 bar −1 . Temperature control was set using the Berendsen thermostat [30] at 300 K. Each component of the system was included in separated heat bath, with temperatures coupling constants of 0.30 ps. The lipid membrane was built using the same approach described in our previous work [31] . The membranes are composed by ceramid-2, lignoceric acid, cholesterol, and cholesterol sulphate. The stratum corneum is composed by repeating units of double bilayers of this lipids. The separation between bilayers is around 5Å, and the separation between the repeating double bilayers is typically 25Å.
In all cases, the fullerene molecules were positioned randomly in water at the beginning of the simulations. The total simulation time, after the initial 20 ns of equilibration, was 1 μs for each simulation. For the simulations with several fullerene molecules the same conditions were applied. The objective is to demonstrate the behavior of the system under different concentrations of fullerene molecules. The number of added fullerene molecules has no direct correlation with experimental concentration.
In addition, a pulling simulation was performed for the fullerene molecule crossing the membrane, in order to calculate the potential of mean force of the process. For this, after an equilibration step of 20 ns, a 20 ns simulation with a pull rate of 0.3 nm/ns and a pull force constant of 1000 kJ/(mol nm 2 ) was run.
Results and discussion
The method used to prepare C 60 dispersions was throughout a single phase mixture. Fullerene C 60 at a concentration of 0.8 mg/mL was mixed in three different solutions: in IPM, in IPM with 20% TRC and in water. The samples were stirred until forming a uniform solution. Fullerene C 60 dispersed in IPM and in IPM with TRC, but did not disperse in water as pristine fullerenes are insoluble in water. Dispersions showed a characteristic brown color (Fig. 1) . After preparation of the dispersions, UV-vis spectroscopy was used to measure the presence of the fullerenes C 60 (Fig. 2) . All dispersions show a characteristic absorption peak located between 330-340 nm due to the presence of C 60 molecules [32] . The UV-vis spectrum confirmed the visual observation of the samples, the (darker) solution of IPM with TRC presented larger quantities of the C 60 . Fullerene C 60 in toluene was used as control sample for the absorption spectrum.
The poor solubility of fullerene C 60 in aqueous solutions has captured the attention of researchers. Basically this problem has been overtaken by functionalization [33, 34] . A variety of investigations of well-characterized compounds for potential applications in biomedicine have been conducted in biopharmaceuticals and cosmetics [2, [35] [36] [37] ]. An alternative, simpler, way for fullerene C 60 application has also been explored using fatty acid esters of glycerol as biocompatible solvents. The solubility of fullerene C 60 can be effective using vegetable oils [24, 38, 39] . This prompted us to study C 60 dispersions with suitable oils for cosmetics/pharma applications: the isopropyl myristate associated with transcutol. IPM presents good spreading properties and is easily absorbed into the skin constituting an excellent substitute for natural oils [40] . The presence of transcutol in the solution of IPM allowed a better dispersion of the fullerene C 60 due to its powerful solubilization properties. In addition, the nontoxicity and biocompatibility of transcutol with the skin also makes it an attractive penetration enhancer [41, 42] .
The quantitative and qualitative permeation of the fullerene C 60 was investigated through in vitro transdermal perfusion using Franz diffusion cells. Porcine skin was used because presents thickness and absorption rates similar to those of human skin [43] [44] [45] [46] [47] [48] [49] [50] [51] . The pig skin was removed from the Franz diffusion cell after the incubation period.
Then, the liquid in donor and receptor compartments was analyzed to measure the fullerene C 60 concentration in each compartment. For that, a simple LLE method was used. The calibration curve was previously obtained by fullerene C 60 solutions dissolved in toluene. Thus, fullerene C 60 that crossed the entire length of the skin until reach the receptor compartment (in the aqueous phase) was extracted to toluene by LLE (using equal volumes: 5 mL). After addition of toluene two immiscible phases were formed. After vigorous agitation the fullerene C 60 was separated. After separation, the phase containing the fullerene C 60 was removed and quantified by its UV-vis absorbance at 340 nm. About 10% of fullerene C 60 remained on top (donor) and 14% of fullerene C 60 crossed the skin until the receptor compartment. The difference between the detected amount of fullerene C 60 in donor and in receptor compartment was 76% meaning that fullerene C 60 was mainly retained into the skin.
The qualitative permeation of the fullerene C 60 through the intact skin was investigated by transmission electron microscopy (TEM) analysis. The integrity of the skin was monitored and maintained intact to ensure a valid permeation profile of the fullerene C 60 through the pig skin. Prior to the TEM analysis the skin samples were washed to remove any compounds of the formulation. The samples were frozen at -80°C for later sectioning and mounting in copper grids for TEM visualization. The dispersed fullerene C 60 was able to cross the intact skin from stratum corneum until dermis layer, the inner layer of the skin. The localization and permeation extend of fullerene C 60 is depicted by TEM analysis in Fig. 3 that clearly show the presence of C 60 aggregates in the skin sample. This is consistent with the results attained by in vitro permeation profile (quantitative assessment) as well as by molecular dynamics simulations (Fig. 4) .
After the experimental evidence on the ability of fullerene C 60 to cross the skin, molecular dynamics simulations were performed to clarify the mechanism leading to the penetration of the fullerene molecules into the skin. Drug molecules in contact with the skin surface can penetrate by three potential pathways: through the sweat ducts, via the hair follicles and sebaceous glands (collectively called the shunt or appendageal route), or directly across the stratum corneum [52] . However, it is generally accepted that as the appendages comprise a fractional area for permeation of approximately 0.1%, the major contribution to steady-state flux of most drugs come from the stratum corneum. Our model of the stratum corneum is a model of the lipidic membrane. To penetrate through the skin, the molecules have to cross the lipidic membrane, as this membrane occupies the spaces between the corneocytes. Our molecular models show that the fullerene C 60 has the ability to penetrate the membrane unaided, Fig. 4 . It is also possible to observe that for higher concentrations (Fig. 4, B2) , the fullerene molecules form aggregates inside the membrane, which is in line with our TEM experiments and previous computer simulations in similar systems [53] . Fullerene aggregates are not present at lower concentrations (Fig. 4, A2) .
Full permeation of the fullerene C 60 throughout the membrane was not observed in our MD (1 μs) simulations. Either the process is kinetically unlikely, or the symmetry conditions in this type of simulations, with periodic boundary conditions lack the driving force necessary to observe the complete permeation as the top layer of the membrane shares the same chemical potential with the bottom layer.
In order to study the complete permeation of C 60 , the changes in the free energy for a fullerene C 60 molecule traversing the membrane were computed. After a pulling simulation, represented in Fig. 5 , the potential of the mean force across the trajectory was determined through umbrella sampling. On Fig. 6 is depicted the variation of potential of mean force calculated across the trajectory of the pulling simulation of fullerene. It is not easy for fullerene molecules to cross the water layers inside the lipid membrane, and the charged head groups of the lipids, in contact with water could have a major influence in this behavior. As previously observed the opening of the lipid membrane has an activation barrier [54] and the fullerenes are stabilized (have negative-free energy) in the apolar, lipid tails, regions.
The membrane model is a small one, with only four lipid bilayers, yet the energetics of a C 60 molecule on the four bilayers are different and cannot be extrapolated from single bilayer models. In fact, the computed energetics indicate that the penetration of the fullerene into the deeper layers of the skin is a favorable process, as the potential of the mean force value for the second bilayer is almost the double of the value for the first bilayer. In addition, there is a sizeable energy barrier at ζzero that could be an indication that it is energetically difficult to cross the inner water layers inside the skin, but that value could be a consequence of the symmetry of the model. Note also, that this is a highly idealized model and the lipid organizations in the skin may not be as straight as in the simulations allowing for permeation routes that avoid water layers.
Concluding remarks
The application of fullerene C 60 for transdermal delivery was assessed and validated through in vitro tests using pig skin as a model. Fullerene C 60 was found to be able to cross the intact skin after its dispersion in a solution of fatty acids (IPM with 20% TRC). To ensure the validation and the relevance of the obtained fullerene C 60 permeation, the integrity of the skin was maintained throughout all experiments. The successful permeation of fullerene C 60 into the dermis layer was supported by molecular dynamics simulations. These results reveal that a simple formulation using fatty acids can deliver fullerene C 60 transdermally. From here the use of fullerene C 60 could be expanded in an easier and greener implementation for the cosmetics/pharmaceutical use. Skin aging and health in general could be improved by the inherent benefits of the antioxidant properties of the fullerene C 60 . As far as we know there is no cosmetic/pharmaceutical formulation available using fullerene C 60 in isopropyl myristate and/or transcutol. These dispersions make fullerene C 60 suitable to be delivered transdermally by direct application in the skin without harsh organic solvents or any chemical modification or encapsulation process.
The benefits of antioxidants have been extensively investigated, particularly in general heath (e.g. extending the lifespan) or in skin aging (delaying the normal aging process).
This study was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UID/BIO/04469/2013 unit and COMPETE 2020 (POCI-01-0145-FEDER-006684).). Artur Ribeiro thanks FCT for the SFRH\BPD\98388\2013 grant.
The authors have declared no conflict of interest.
